Hasta La Creative!

More than five years ago, when the Federal Trade Commission issued new endorsement disclosure rules for social media marketing, Ann Taylor Loft was one of the first companies to get dinged for giving social influencers incentives to write about its brand. Fast-forward to today, and Kim Kardashian’s missteps endorsing a morning-sickness drug show marketers still haven’t gotten it right.

Ms. Kardashian, who had been paid to promote the anti-nausea drug Diclegis, may have broken FTC rules when she endorsed the product in social media with only the vague disclosure that she was “so excited and happy” about the drug’s results for her that she was “partnering” with its maker “to raise awareness about treating morning sickness.”

And the star violated strict FDA pharmaceutical marketing regulations, which require marketers to prominently disclose prescription drugs’ safety risks when and where they promote the drugs’ benefits.

Continue reading at AdAge.com